HVAX Technologies SME IPO Details, Financials, Valuation & Peers

HVAX Technologies Limited, founded in 2010, is a specialized provider of turnkey projects in controlled environment infrastructure and cleanroom solutions. Initially established as an HVAC project contractor, the company has evolved into a comprehensive design-to-delivery solution provider for the pharmaceutical, healthcare, chemical, hospital, and FMCG sectors. HVAX delivers engineering, procurement, and execution services, alongside design, consultancy, and equipment supply. The company's expertise lies in providing end-to-end solutions encompassing design, engineering, procurement, installation, testing, commissioning, and operational support. HVAX has completed over 200 projects across 15 countries, including India, UAE, Kenya, and South Africa. HVAX also offers a range of third-party manufactured products, such as cleanroom panels, doors, air handling units, and building management systems.

Key Points:

• Business Focus:
  • HVAX specializes in turnkey projects for controlled environment infrastructure and cleanrooms, primarily for the pharmaceutical, healthcare, chemical, hospital, and FMCG industries.
  • Services include design, engineering, procurement, installation, testing, commissioning, and consultancy for cleanroom and HVAC systems.
• Product Offerings: HVAX supplies a variety of third-party manufactured products such as cleanroom wall and ceiling panels, flooring systems, air handling units, chillers, LT/HT electrical panels, and more.
• Global Presence:
  • The company has completed over 200 projects across 15 countries, including Algeria, Ethiopia, UAE, Ghana, Kenya, New Zealand, Nigeria, Saudi Arabia, and others.
• End-to-End Solutions:
  • HVAX provides end-to-end project solutions, from design and engineering to installation, testing, and operational support, ensuring timely project completion.
• Consultancy Services:
  • The company also offers design, engineering, and consultancy services, including GAP analysis, validation, technology transfer, and project feasibility studies, particularly for the pharmaceutical sector.